Dr Lazar Remen (1907-74): a forgotten pioneer in the treatment of myasthenia gravis.
Dr Lazar Remen (1907-74) was the first, in 1932, to describe the beneficial effect of prostigmine on a myasthenia gravis patient. His observation actually preceeded by two years Mary Broadfoot Walker's (1888-1974) paper, which is considered to be the landmark article on this association.
Ohry
Avi
A
Rehabilitation Medicine, Tel Aviv University's Faculty of Medicine and Chairman, Section of Rehabilitation Medicine, Reuth Medical Center, Tel-Aviv, Israel. aohry@bezeqint.net
D002800:Cholinesterase Inhibitors / Q000266:history* / Q000627:therapeutic use; D005858:Germany; D049673:History, 20th Century; D006801:Humans; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000266:history*; D009388:Neostigmine / Q000266:history* / Q000627:therapeutic use
D002800:Cholinesterase Inhibitors; D009388:Neostigmine